Teva Loses Generic Copaxone Lawsuit Against FDA

Teva makes a move to block rivals including Mylan Inc. and Novartis AG’s Sandoz unit from making a less expensive generic drug
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news